Mackenzie Financial Corp decreased its stake in shares of CME Group Inc (NASDAQ:CME) by 12.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 301,894 shares of the financial services provider’s stock after selling 41,178 shares during the period. Mackenzie Financial Corp owned about 0.09% of CME Group worth $40,961,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. ST Germain D J Co. Inc. purchased a new position in shares of CME Group during the third quarter valued at approximately $232,000. Capital Advisors Inc. OK boosted its position in shares of CME Group by 10.7% during the second quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock valued at $10,587,000 after buying an additional 8,198 shares during the last quarter. Marvin & Palmer Associates Inc. lifted its holdings in CME Group by 100.7% during the second quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after acquiring an additional 28,745 shares during the period. Captrust Financial Advisors bought a new stake in CME Group during the second quarter worth $693,000. Finally, Commerce Bank lifted its holdings in CME Group by 3.8% during the second quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock worth $70,247,000 after acquiring an additional 20,449 shares during the period. 83.17% of the stock is currently owned by institutional investors.
Shares of CME Group Inc (CME) opened at $152.11 on Wednesday. The stock has a market capitalization of $51,135.15, a price-to-earnings ratio of 31.55, a price-to-earnings-growth ratio of 3.10 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group Inc has a one year low of $113.27 and a one year high of $155.29.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Friday, December 8th will be paid a $0.66 dividend. The ex-dividend date is Thursday, December 7th. This represents a $2.64 annualized dividend and a dividend yield of 1.74%. CME Group’s payout ratio is presently 59.86%.
In related news, insider Hilda Harris Piell sold 1,350 shares of the business’s stock in a transaction on Thursday, October 5th. The stock was sold at an average price of $138.00, for a total transaction of $186,300.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Dennis Suskind sold 750 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $129.34, for a total value of $97,005.00. Following the sale, the director now owns 5,059 shares in the company, valued at $654,331.06. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,921 shares of company stock worth $5,016,248. Corporate insiders own 0.57% of the company’s stock.
A number of analysts recently commented on CME shares. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 18th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price target on shares of CME Group in a report on Friday, August 18th. UBS reiterated a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Barclays started coverage on CME Group in a report on Friday, September 8th. They set an “overweight” rating and a $139.00 price target on the stock. Finally, Wells Fargo & Company lifted their price target on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $141.75.
ILLEGAL ACTIVITY WARNING: “Mackenzie Financial Corp Has $40.96 Million Position in CME Group Inc (CME)” was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://stocknewstimes.com/2017/12/06/mackenzie-financial-corp-has-40-96-million-position-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.